All In MedTech

FDA Clearance Tracker · P080011-S015

COOPERVISION COMFILCON A SOFT EXTENDED WEAR CONTACT LENSES

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 18, 2012 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080011-S015
Device name
COOPERVISION COMFILCON A SOFT EXTENDED WEAR CONTACT LENSES
Applicant location
San Ramon, CA
Received
Jun 21, 2012
Decided
Dec 18, 2012
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P080011

Device type

Device class
Class III
Regulation
21 CFR 886.5925
Specialty
Ophthalmology

Every decision under product code LPM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ADDITION OF A NEW PRIVATE LABEL BRAND NAME BREATHABLES XW.

Source documents

Other decisions for CooperVision, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.